Rybelsus 7 mg tablets, Placebo (semaglutide) tablets, Rybelsus 3 mg tablets, Rybelsus 14 mg tablets
NN6535-4730
Phase 3 small_molecule active
Quick answer
Rybelsus 7 mg tablets, Placebo (semaglutide) tablets, Rybelsus 3 mg tablets, Rybelsus 14 mg tablets for Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type is a Phase 3 program (small_molecule) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Mild cognitive impairment (MCI) or mild dementia, both of the Alzheimer’s type
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active